Results 41 to 50 of about 76,081,297 (156)

Siglec-15 promotes progression of clear renal cell carcinoma [PDF]

open access: yesChinese Medical Journal, 2021
Wen-Bo Yang   +5 more
doaj   +2 more sources

Anti-Siglec-15 antibody suppresses bone resorption by inhibiting osteoclast multinucleation without attenuating bone formation [PDF]

open access: yes, 2021
Tsukazaki H., Kikuta J., Ao T., et al. Anti-Siglec-15 antibody suppresses bone resorption by inhibiting osteoclast multinucleation without attenuating bone formation.
Kikuta, Junichi   +9 more
core   +2 more sources

Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters

open access: yesEuropean Journal of Histochemistry, 2021
The sialic acid-binding immunoglobulin-type lectin Siglec-15 is a promising target to cancer immunotherapy in several tumor types. The present study aimed to investigate Siglec-15 expression in gastric cancer (GC) patient tissue and to evaluate its ...
Michael Williams Leal Quirino   +9 more
doaj   +1 more source

Comprehensive Analysis of SIGLEC-15 and PD-L1 Expression Identifies Distinct Prognostic Profiles in Gastric Cancer. [PDF]

open access: yesInt J Mol Sci
Gastric cancer remains a major global health burden, with limited response rates to current immunotherapies targeting the programmed death-ligand 1 (PD-1/PD-L1) axis.
Cozac-Szőke AR   +13 more
europepmc   +2 more sources

Siglec-9 blocking antibody characterization.

open access: yes, 2021
(A) Binding ELISA of anti-Siglec-9 antibody. Recombinant human Siglec-9 protein was used in ELISA to assess the antigen-specific binding of the Siglec-9 blocking antibody. His-tag protein was used as a negative control.
Han Xiao (373894)   +16 more
core   +1 more source

Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients

open access: yesScientific Reports, 2021
Sialic acid-binding immunoglobulin-like lectin-15 (Siglec-15) is a new immune checkpoint molecule and its role of primary central nervous system lymphoma (PCNSL) tumor microenvironment has been unclear.
Hirotaka Fudaba   +8 more
doaj   +1 more source

Siglec-9+ CD56dim NK cells express CD7.

open access: yes, 2021
Fresh human PBMCs from an HIV-negative donor were stained for CD3, CD56, CD7, and Siglec-9. The majority of Siglec-9+ CD56dim NK cells express CD7, decreasing the chance that these cells are monocytes. FMO = Fluorescence Minus One. (EPS)
Han Xiao (373894)   +16 more
core   +1 more source

Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases

open access: yesJournal of Biomedical Science, 2020
Siglec-15 is a member of the Siglec family of glycan-recognition proteins, primarily expressed on a subset of myeloid cells. Siglec-15 has been known to be involved in osteoclast differentiation, and is considered to be a potential therapeutic target for
Takashi Angata
doaj   +1 more source

Siglec-9+ CD56dim cells exhibit lower cytotoxicity towards K562 cancer cells compared to Siglec-9- CD56dim.

open access: yes, 2021
Cytotoxicity was assessed using NK degranulation and IFNγ production (E: T = 4:1). Total NK cells were gated on Siglec-9+ or Siglec-9- CD56dim NK cell subsets.
Han Xiao (373894)   +16 more
core   +1 more source

Siglec-E promotes β2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung [PDF]

open access: yes, 2014
Siglec-E is a sialic acid-binding Ig-like lectin expressed on murine myeloid cells. It has recently been shown to function as a negative regulator of ß2-integrin-dependent neutrophil recruitment to the lung following exposure to lipopolysaccharide (LPS).
Hegde, Vikas   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy